Issue link: https://www.e-digitaleditions.com/i/1032386
Drug Delivery to the Lungs (DDL) 2018 will take place December 12-14, 2018 at the Edinburgh International Conference Centre in Edinburgh, UK. A preview of DDL2018 and the IPAC-RS workshop When? December 12-14, 2018 Where? Edinburgh, UK For more information and registration: www.ddl-conference.com Drug Delivery to the Lungs (DDL) 2018 will take place Decem- ber 12-14, 2018 at the Edinburgh International Conference Centre in Edinburgh, UK. e conference will begin with the DDL lecture; session themes will be lung diseases and treatments, real-world challenges, thinking outside the box, physics meets pharmaceutics, and novel formu- lations and process technology. e scienti c posters and product exhibition will be co-located to facilitate networking. Multiple awards During the conference, several awards will be presented, includ- ing the DDL Emerging Scientist A w a r d a n d t h e P a t B u r n e l l Award, which lets a young scien- tist present their work as a poster and on the podium. e best aca- demic poster and best industry poster will also be recognized. IPAC-RS pre-conference workshop A pre-conference workshop on the morning of Wednesday, December 12 will be presented by IPAC-RS on industry's positions regarding the 2018 US FDA draft guidance for MDIs and DPIs, the European Medical Device Regulations and pharmacopeial updates. 14 OCTOBER 2018 Inhalation Medical Devices Made Easy www.merxin.com info@merxin.com Tel: +44 (0)1223 787300 MRX003 is a "505j" generic capsule inhaler for tiotropium DPI. It is the only "off-the-shelf " commercially available "505j" opportunity for tiotropium DPI in the industry. MERXIN: Reduce Cost, Reduce Risk, Increase Success. GENERIC & CUSTOMISED MRX003 is a "505j" generic capsule inhaler for CUSTOMISED